ESC 365 - Doctor Anca Daniela Farcas

Speaker illustration

Doctor Anca Daniela Farcas

University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)

Could diastolic perfomance parameters be earlier markers for cardiotoxicity in high risk cancer patients?

Event: ESC Congress 2020

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations ePosters

The role of ST2 as an early marker of endothelial dysfunction in hypertensive patients

Event: ESC Congress 2019

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Session: Hypertension mediated target organ damage and hypertension phenotypes

Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension treatment old and new

Heart failure with mid-range ejection fraction - an echocardiographic finding or a clinical phenotype?

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Chronic pulmonary hypertension

Session: Chronic heart failure

Metoprolol and carvedilol in heart failure - different mechanisms, similar effect?

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Beta blockers

Session: Beta blockers

Improving blood pressure control beyond the guidelines

Event: ESC Congress 2016

Topic: Treatment of hypertension

Session: Drug treatment of hypertension

The lymphocyte count and neutrophil/lymphocyte ratio as independent predictors for cardiac events in heart failure only in ischemic heart disease patients

Event: HEART FAILURE 2016

Topic: Inflammation

Session: Biomarkers

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources